<?xml version="1.0" encoding="UTF-8"?>
<ref id="b26-1040986">
 <label>26.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gokbuget</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Zugmaier</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Klinger</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia</article-title>. 
  <source>Haematologica</source>. 
  <year>2017</year>;
  <volume>102</volume>(
  <issue>4</issue>):
  <fpage>e132</fpage>â€“
  <lpage>e135</lpage>.
  <pub-id pub-id-type="pmid">28082340</pub-id>
 </mixed-citation>
</ref>
